MOTS-c 10mg

MOTS-c 10mg

SEQUORA’s 10 mg MOTS-c contains a synthetic version of a naturally occurring mitochondrial peptide studied for its role in cellular energy use, glucose metabolism and AMPK signalling. Research also explores its relevance to age-related metabolic changes in men and women, including changes associated with menopause.

Apply for a Trade Account

SEQUORA’s MOTS-c 10mg contains a synthetic version of a mitochondrial-derived peptide studied for its role in cellular energy regulation, glucose metabolism and responses to metabolic stress. Early research has explored its effects on insulin sensitivity and physical performance. MOTS-c has been investigated for its benefits for women in perimenopause or postmenopause who are going through metabolic shifts, weight gain and changing energy levels without clear explanation.

Choose your product format
  • 10mg vial: a 10mg sealed vial of lyophilized powder (freeze dried). This format extends the shelf-life significantly and also allows freezer storage of your MOTS-C. This vial can then be mixed with Bacteriostatic Water (BAC water) and be used as an injectable MOTS-c compound.
  • 10mg prefilled pen: A prepared reconstituted MOTS-c Blend in a 3ml cartridge. This is then inserted into a SEQUORA disposable injector pen for easy use and dosing.

The 10mg figure indicates the total stated content, not the concentration or amount delivered per withdrawal. Review the specifications for your selected format.

Purity & Verification

All of our products are third party laboratory tested to ensure both purity and verification of the peptide itself.

What is MOTS-c 10mg used For?

MOTS-c is a mitochondrial-derived peptide studied for its role in cellular energy regulation, glucose metabolism and responses to metabolic stress. Research also explores exercise adaptation and age-related metabolic changes, including those associated with menopause.

What are the benefits of MOTS-c 10mg?

Effects on metabolic regulation, muscle function and cellular stress responses. Research involving women’s health also found changes associated with declining oestrogen, combating the effects of perimenopause and postmenopause.

Why buy MOTS-c 10mg from SEQUORA?

SEQUORA’s MOTS-c delivers accurate dosing, confirmed, third-party tested purity and ease of use. Available in both 10mg vial and 10mg prefilled pen formats, our MOTS-c can help with metabolic health in both men and women.

Questions & Answers

What can MOTS-c do for women specifically?

MOTS-c is a peptide produced by the mitochondria, the parts of your cells that help generate energy. Researchers are studying its role in insulin sensitivity and how the body uses glucose. There’s also interest in its relevance during perimenopause and after menopause, when falling oestrogen can affect metabolism.

Yes. MOTS-c occurs naturally in both men and women. Research explores metabolic health, muscle function and age-related changes, making it relevant beyond women’s health.

Can MOTS-c help with weight loss or exercise performance?

Studies have reported improvements in metabolic function and physical performance, meaning MOTS-c has been found in certain environments to help with weight management and exercise.

In studies, metabolic improvements were observed over weeks to months, not days. Given that the underlying conditions MOTS-c targets: insulin resistance, metabolic aging, develop over years, it’s reasonable to expect meaningful assessment would require at least 8-12 weeks of use alongside objective metabolic monitoring, such as HbA1c, fasting insulin, and continuous glucose data.

Product Information Guide

MOTS-c

Product information, handling and safety

Storage

What Temperature should I store my MOTS-c at?

Safety

What are the best practices for using MOTS-c safely?

Evidence

The documentation behind MOTS-c and it's uses

What is MOTS-c?

SEQUORA’s 10 mg MOTS-c contains a synthetic version of a naturally occurring mitochondrial peptide studied for its role in cellular energy use, glucose metabolism and AMPK signalling. Research also explores its relevance to age-related metabolic changes in men and women, including changes associated with menopause.

Storage & Handling

Storage

Upon delivery store in a refridgerator between 2-8°C.

  • Avoid storing at the very back of the refridgerator.
  • Avoid exposure to heat, direct sunlight and temperature fluctuations.
  • Never freeze your SEQUORA MOTS-c Pens (Vials are safe to be frozen BEFORE reconstitution only).

Handling

Avoid dropping or heavy-handling of your MOTS-c.

Please do not freeze your SEQUORA MOTS-c Pen as this can compromise the peptide.

Your product has been shipped in secure packaging to prevent any potential issues however if you believe your peptides have been compromised contact us directly.

shelf-life

Your SEQUORA MOTS-c Pen will last 12 months from the date of manufacture providing you follow the storage instructions provided.

SEQUORA MOTS-c Vials before reconstitution can last up to 4 years at -5°C

MOTS-c can be kept at room temperature however it’s shelf life when held at this temperature reduces to 1-2 months.

Safety & Hygiene

pre-use hygiene

Before handling your MOTS-c, needles or injection material, ensure your research area is clean and clear.

Wash your hands with warm water and soap and allow to dry fully before handling any SEQUORA products to prevent cross contamination or infection risks.

If at any point the cleanliness of your injection or environment is compromised, restart this step.

needle & injection safety

Never re-use or share needles/syringes. Ensure your needle tips or syringe is sealed and new before injection.

Before using your SEQUORA MOTS-c Pen, using an alcohol swab, wipe the tip of the cartridge after removing the lid to the pen.

If at any point you touch something unhygienic or potentially dirty, re-wash your hands and use new equipment.

post-injection guidance

Ensure that your needle tips, syringes and vials are safely disposed of post-use.

This could mean a sharps bin or safe container. Most needle tips and syringes have removable tops that can be replaced onto the used needle.

Try to keep your injection site clean for atleast 30 minutes post-injection to prevent infection risks.

Potential MOTS-c Side Effects

MOTS-c is an investigational peptide with a favourable and optimistic safety profile in published research data. It is a peptide thats natural form circulates in human blood and Phase 1 Data and clinical experiments report no serious adverse avents on doses up to 10mg per injection.

Injection-site reactions

  • Redness, irritation or soreness
  • Minor bruising associated with needle administration
  • Possible local swelling or an immune reaction

These reactions may relate to the preparation, its ingredients or injection technique. Persistent or worsening symptoms should not be dismissed as a normal adjustment period.

Fatigue and headache

Fatigue and headache are described in some informal accounts and promotional summaries, but their frequency, cause and expected duration have not been established through adequate human trials of MOTS-c.

There is insufficient evidence to explain these symptoms as a harmless shift in energy metabolism or AMPK activation.

Other reported symptoms

Safety information about online MOTS-c use also describes palpitations, increased heart rate, sleep disturbance, fever and immune-type reactions. These reports are not verified clinical adverse-effect rates and cannot establish causation.

Blood glucose precautions

Preclinical research suggests effects on glucose metabolism. Whether injected MOTS-c causes clinically important low blood glucose in humans is uncertain. People using insulin or other medicines that can cause hypoglycaemia require particular caution and medical assessment.

Pregnancy and breastfeeding

Avoid use during pregnancy or breastfeeding because adequate safety information is unavailable.

When to seek medical help

Seek prompt assessment for persistent headache, marked fatigue, palpitations, fever or increasing injection-site redness, warmth, swelling or pain.

Call 999 immediately for difficulty breathing, sudden swelling of the lips, tongue or throat, chest pain, collapse or seizures.

About this information

The absence of documented harm in limited research does not establish the absence of liver, kidney, cardiovascular or other risks. This summary does not establish the safety, quality or suitability of a SEQUORA product for human use and does not replace medical advice.

MOTS-c Side Effect Mitigation

The measures below address symptoms and preparation uncertainties in MOTS-c.

Injection-site irritation or bruising

  • Do not administer further injections into irritated, bruised or damaged skin.
  • A clean, cool compress may help minor local discomfort. Do not apply ice directly to the skin.
  • Seek medical assessment for spreading redness, increasing warmth, swelling, discharge or fever.
  • Do not attempt to resolve a reaction by adding more water, changing the diluent or altering the solution’s pH without professional guidance.

Fatigue or headache

  • Rest and maintain normal food and fluid intake unless you have been advised otherwise.
  • Avoid driving or hazardous activities if alertness is affected.
  • Seek advice if symptoms persist, worsen or affect daily functioning.
  • Do not assume symptoms are a beneficial metabolic adjustment, or add stimulants to overcome them.

Palpitations or disturbed sleep

Stop use and seek medical advice for a new racing or irregular heartbeat or significant sleep disturbance. Avoid adding stimulant pre-workouts or additional research compounds while symptoms are assessed.

Call 999 for palpitations accompanied by chest pain, breathlessness or fainting.

Blood glucose precautions

  • Discuss any proposed exposure with your diabetes team if you use insulin or other medicines that can cause hypoglycaemia.
  • Do not reduce or omit prescribed diabetes treatment on the assumption that MOTS-c replaces it.
  • If symptoms suggest low blood glucose, check your level where possible and follow your existing diabetes treatment plan.
  • Do not give food or drink to someone who is unconscious or cannot swallow safely. Call 999.

Pregnancy and breastfeeding

Avoid use during pregnancy or breastfeeding. If exposure has occurred, seek individual medical advice rather than assuming harm has occurred.

About this information

There is no established safe dose or proven strategy for preventing MOTS-c reactions. Clinical supervision and pharmacy supply do not, by themselves, establish regulatory approval or eliminate uncertainties about an unapproved preparation.

Dosing Guidance For MOTS-c 10mg

Calculation basis: 10 mg total compound in a final solution volume of 1 ml, giving a concentration of 10 mg/ml. Each pen dial unit is assumed to deliver 0.01 ml, containing 0.1 mg.

DOSE SCHEDULE PEN DIAL SETTING WEEKLY TOTAL
5 mg per injection Once weekly 50 5 mg
2.5 mg per injection Mon / Thu 25 per injection 5 mg

Understanding the figures

The 10 mg figure represents the total stated compound content, not an individual dose. At a final volume of 1 ml, each dial unit delivers 0.01 ml containing 0.1 mg (100 mcg). A setting of 25 therefore delivers 0.25 ml containing 2.5 mg, while a setting of 50 delivers 0.5 ml containing 5 mg.

Pen settings apply to each individual administration. These calculations only apply to a concentration of 10 mg/ml and a device confirmed to deliver 0.01 ml per dial unit.